Skip to main content

Table 3 Characteristics of all patients by mobility status

From: Feasibility of mobilisation in ICU: a multi-centre point prevalence study of mobility practices in the UK

 

Mobilised

Not mobilised

Non-physiological barriers

p

N

393

416

151

 

Type of admission (%)

< 0.001

Elective surgery

139 (35.4)

69 (16.6)

23 (15.2)

 

Emergency surgery

70 (17.8)

93 (22.4)

36 (3.8)

 

Medical

163 (41.5)

225 (54.1)

68 (45.0)

 

Other

21 (5.3)

29 (6.9)

24 (15.9)

 

Gender = male (%)

251 (63.9)

255 (61.3)

100 (66.2)

0.519

RRT (%)

17 (4.3)

70 (16.8)

13 (8.6)

< 0.001

Airway

< 0.001

Nasal ETT

0 (0.0)

1 (0.2)

0 (0.0)

 

Oral ETT

9 ( 2.3)

236 (56.7)

38 (25.2)

 

Own

307 (78.1)

105 (25.2)

70 (46.4)

 

Tracheostomy

77 (19.6)

74 (17.8)

43 (28.5)

 

Nova lung (%)

1 (0.3)

2 (0.5)

0 (0.0)

1

ECMO (%)

2 (0.5)

4 (1.0)

4 (2.6)

0.113

Cardiac assist device (%)

0.054

BiVAD

3 (0.8)

2 (0.5)

0 (0.0)

 

IABP

0 (0.0)

7 (1.7)

0 (0.0)

 

LVAD

1 (0.3)

0 (0.0)

0 (0.0)

 

RVAD

2 (0.5)

0 ( 0.0)

0 (0.0)

 

TAH

1 (0.3)

0 (0.0)

0 (0.0)

 

FiO2 (median [IQR])

0.24 [0.21, 0.32]

0.30 [0.25, 0.40]

0.25 [0.21, 0.34]

< 0.001

PF (median [IQR])

40.94 [30.64, 51.03]

35.68 [25.49, 45.10]

44.12 [30.37, 52.87]

< 0.001

Haemoglobin (mean (SD))

97.21 (23.83)

93.93 (21.02)

92.08 (23.73)

0.028

CRP (median [IQR])

59.00 [19.00, 123.08]

83.00 [31.50, 155.05]

63.00 [21.00, 149.00]

0.008

WCC (median [IQR])

10.30 [7.90, 13.70]

11.50 [8.33, 15.80]

9.93 [7.90, 14.00]

0.001

MAP (mean (SD))

86.83 (14.14)

84.17 (15.90)

85.16 (13.78)

0.039

HR (mean (SD))

85.25 (17.55)

86.45 (20.14)

86.22 (18.29)

0.651

VIS total (median [IQR])

0.00 [0.00, 0.00]

0.00 [0.00, 4.00]

0.00 [0.00, 0.00]

< 0.001

Metaraminol dose (mean (SD))

1.09 (0.56)

0.99 (0.53)

1.01 (0.51)

0.847

  1. ETT, endotracheal tube; ECMO, RRT, renal replacement therapy, extracorporeal membrane oxygenation; BiVAD, biventricular assist device; IABP, intra-aortic balloon pump; LVAD, left ventricular assist device; RVAD right ventricular assist device; TAH, total artificial heart, FiO2, fraction of inspired oxygen, PF, PaO2 (Kpa) fraction of inspired oxygen ratio, CRP, C reactive protein, WCC,  white cell count, MAP, mean arterial pressure, HR, heart rate, VIS, vasoactive-inotropic score